Lv1
48 积分 2024-07-31 加入
Trends in the drug target landscape for autoimmune diseases
1个月前
已完结
Mapping Receptor Binding Sites in Interleukin (IL)-1 Receptor Antagonist and IL-1β by Site-directed Mutagenesis
1个月前
已完结
Strategies for targeting cytokines in inflammatory bowel disease
2个月前
已完结
Navigating the complexities of drug development for inflammatory bowel diseaseMay 2024 Nature Reviews Drug Discovery 23(7)
2个月前
已完结
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
2个月前
已完结
Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy
8个月前
已完结
Molecular mechanisms of DNA lesion and repair during antibody somatic hypermutation
9个月前
已完结
Strategies for targeting cytokines in inflammatory bowel disease
10个月前
已完结
TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease
10个月前
已完结
皖公网安备34019202002308
